| abstract |
Disclosed is the discovery and acquisition of a human gene for GlyT2, which is one of the two types of glycine transporters whose presence is currently known, to elucidate, treat, and prevent diseases involving glycine in humans. It is desired to contribute more widely. A method for detecting whether an animal has an autoimmune antibody against a human glycine T-2 transporter, wherein an antibody sample from the animal or a body fluid from the animal contains the human glycine T-2 transporter. Or a polypeptide antigen derived from the glycine transporter, wherein the polypeptide antigen has SEQ ID NO: 27 and its substitute amino acid sequence, or the nucleic acid sequence of SEQ ID NO: 26, or A method that is encoded by a substitution sequence. [Selection figure] None |